Form 4 for CNMD CONMED Corp
Accepted 2021-09-17 00:00:00 ET · period of report 2021-09-15 · accession 0001127602-21-025507 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-17 | 2021-09-15 | CNMD | Jonas Daniel S | EVP Legal Affairs, Gen. Counsel | M - OptEx | $59.96 | +11.0K | 21.5K | +105% | +$659.6K |
| D | 2021-09-17 | 2021-09-15 | CNMD | Jonas Daniel S | EVP Legal Affairs, Gen. Counsel | F - Tax | $127.56 | -8,327 | 13.1K | -39% | -$1.06M |
| D | 2021-09-17 | 2021-09-15 | CNMD | Jonas Daniel S | EVP Legal Affairs, Gen. Counsel | S - Sale+OE | $127.26 | -3,357 | 10.5K | -24% | -$427.2K |
| D | 2021-09-17 | 2021-09-15 | CNMD | Jonas Daniel S | EVP Legal Affairs, Gen. Counsel | G - Gift | $0.00 | -1,000 | 12.1K | -8% | $0 |
| D | 2021-09-17 | 2021-09-15 | CNMD | Jonas Daniel S | EVP Legal Affairs, Gen. Counsel | M - OptEx | $0.00 | -11.0K | 11.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-15 | M | A | 11,000 | $59.96 | 21,464 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-15 | F | D | 8,327 | $127.56 | 13,137 | D | — | — | |
| 3 | Common | Common Stock | 2021-09-15 | S | D | 3,357 | $127.26 | 10,464 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.20 to $127.265. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 4 | Common | Common Stock | 2021-09-15 | G | D | 1,000 | $0.00 | 12,137 | D | — | — | |
| 5 | Derivative | Options To Purchase Common Stock | 2021-09-15 | M | D | 11,000 | $0.00 | 11,000 | D | $59.96 · — to 2028-03-01 | 11,000 Common Stock | (F2) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |